These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34689861)

  • 21. Acute baclofen administration promotes functional recovery after spinal cord injury.
    de Sousa N; Pinho AG; Monteiro S; Liberato V; Santos DJ; Campos J; Cibrão JR; Silva NA; Barreiro-Iglesias A; Salgado AJ
    Spine J; 2023 Mar; 23(3):379-391. PubMed ID: 36155240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of 4-Aminopyridine for the Management of Spasticity in Spinal Cord Injury: A Systematic Review.
    Wiener J; Hsieh J; McIntyre A; Teasell R
    Top Spinal Cord Inj Rehabil; 2018; 24(4):353-362. PubMed ID: 30459498
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.
    Saval A; Chiodo AE
    J Spinal Cord Med; 2010; 33(1):16-21. PubMed ID: 20397440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diazepam usage in veterans with spinal cord injury.
    Broderick CP; Radnitz CL; Bauman WA
    J Spinal Cord Med; 1997 Oct; 20(4):406-9. PubMed ID: 9360221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spasticity following spinal cord injury.
    Rekand T; Hagen EM; Grønning M
    Tidsskr Nor Laegeforen; 2012 Apr; 132(8):970-3. PubMed ID: 22562332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of hydrotherapy for the management of spasticity.
    Kesiktas N; Paker N; Erdogan N; Gülsen G; Biçki D; Yilmaz H
    Neurorehabil Neural Repair; 2004 Dec; 18(4):268-73. PubMed ID: 15537997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spasticity and the use of intrathecal baclofen in patients with spinal cord injury.
    Khurana SR; Garg DS
    Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):655-69, ix. PubMed ID: 25064793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life: effect of reduced spasticity from intrathecal baclofen.
    Gianino JM; York MM; Paice JA; Shott S
    J Neurosci Nurs; 1998 Feb; 30(1):47-54. PubMed ID: 9604822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Froin Syndrome After Spinal Cord Injury.
    Decramer T; Wouters A; Kiekens C; Theys T
    World Neurosurg; 2019 Jul; 127():490-491. PubMed ID: 31048043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal baclofen as emergency treatment alleviates severe intractable autonomic dysreflexia in cervical spinal cord injury.
    Delhaas EM; Frankema SPG; Huygen FJPM
    J Spinal Cord Med; 2021 Jul; 44(4):617-620. PubMed ID: 31815605
    [No Abstract]   [Full Text] [Related]  

  • 33. Pain and spasticity after spinal cord injury: mechanisms and treatment.
    Burchiel KJ; Hsu FP
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S146-60. PubMed ID: 11805622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baclofen dosage after traumatic spinal cord injury: a multi-decade retrospective analysis.
    Veerakumar A; Cheng JJ; Sunshine A; Ye X; Zorowitz RD; Anderson WS
    Clin Neurol Neurosurg; 2015 Feb; 129():50-6. PubMed ID: 25532135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin.
    Kawano O; Masuda M; Takao T; Sakai H; Morishita Y; Hayashi T; Ueta T; Maeda T
    Spinal Cord; 2018 Oct; 56(10):996-999. PubMed ID: 29895878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem.
    Priebe MM; Sherwood AM; Thornby JI; Kharas NF; Markowski J
    Arch Phys Med Rehabil; 1996 Jul; 77(7):713-6. PubMed ID: 8670001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of neurorehabilitation to the outcome of neuromodulation in spasticity.
    Petropoulou KB; Panourias IG; Rapidi CA; Sakas DE
    Acta Neurochir Suppl; 2007; 97(Pt 1):243-50. PubMed ID: 17691383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injury.
    Gómez-Soriano J; Goiriena E; Taylor J
    Br J Pharmacol; 2010 Nov; 161(5):972-5. PubMed ID: 20662840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance--a case report and review of literature.
    Soni BM; Mani RM; Oo T; Vaidyanathan S
    Spinal Cord; 2003 Oct; 41(10):586-9. PubMed ID: 14504619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.